Literature DB >> 2942102

Influence of medium and method on the in vitro susceptibility of Pseudomonas aeruginosa and other bacteria to ciprofloxacin and enoxacin.

J Blaser, M N Dudley, D Gilbert, S H Zinner.   

Abstract

Ciprofloxacin and enoxacin were two- to fourfold less active against Pseudomonas aeruginosa in calcium- and magnesium-supplemented broth compared with unsupplemented broth regardless of inoculum size, presence of serum, or use of inhibitory or bactericidal endpoints (P less than 0.01). The effect of cation supplementation was less pronounced and less consistent for Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2942102      PMCID： PMC284183          DOI： 10.1128/AAC.29.5.927

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  15 in total

1.  The quinolones.

Authors:  R J Fass
Journal:  Ann Intern Med       Date:  1985-03       Impact factor: 25.391

2.  Serum dilution test for bactericidal activity. I. Selection of a physiologic diluent.

Authors:  C W Stratton; L B Reller
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

3.  Cephradine concentrations in serum, pleural fluid, pleura, and lung of normal rabbits.

Authors:  S A Sahn; J T Good; L B Reller
Journal:  J Antimicrob Chemother       Date:  1981-10       Impact factor: 5.790

4.  Effect of salt concentration on the apparent in-vitro susceptibility of Pseudomonas and other gram-negative bacilli to gentamicin.

Authors:  A A Medeiros; T F O'Brien; W E Wacker; N F Yulug
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

5.  In-vitro studies with ciprofloxacin, a new 4-quinolone compound.

Authors:  D S Reeves; M J Bywater; H A Holt; L O White
Journal:  J Antimicrob Chemother       Date:  1984-04       Impact factor: 5.790

6.  Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.

Authors:  N X Chin; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

7.  Method of reliable determination of minimal lethal antibiotic concentrations.

Authors:  R D Pearson; R T Steigbigel; H T Davis; S W Chapman
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

8.  Minimum inhibitory and bactericidal concentrations of 44 antimicrobial agents against three standard control strains in broth with and without human serum.

Authors:  L G Reimer; C W Stratton; L B Reller
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

9.  In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim.

Authors:  N X Chin; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

10.  Cefaclor versus amoxicillin in the treatment of bacterial pneumonia: a comparative double-blind study.

Authors:  P Leuenberger; S Vrantchev
Journal:  Eur J Clin Microbiol       Date:  1983-02       Impact factor: 3.267
View more
  13 in total

1.  Pharmacodynamics of trovafloxacin, ofloxacin, and ciprofloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model.

Authors:  P D Lister; C C Sanders
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Resistance to pefloxacin in Pseudomonas aeruginosa.

Authors:  M Michea-Hamzehpour; C Lucain; J C Pechere
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

3.  High concentrations of manganese in Mueller-Hinton agar increase MICs of tigecycline determined by Etest.

Authors:  Carlos Fernández-Mazarrasa; Olav Mazarrasa; Jorge Calvo; Asunción del Arco; Luis Martínez-Martínez
Journal:  J Clin Microbiol       Date:  2009-01-14       Impact factor: 5.948

4.  Interaction of the fluoroquinolone antimicrobial agents ciprofloxacin and enoxacin with liposomes.

Authors:  J Bedard; L E Bryan
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

5.  Synergistic interactions of ciprofloxacin and extended-spectrum beta-lactams or aminoglycosides against multiply drug-resistant Pseudomonas maltophilia.

Authors:  A W Chow; J Wong; K H Bartlett
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

Review 6.  Enoxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J M Henwood; J P Monk
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

7.  Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance.

Authors:  J Blaser; B B Stone; M C Groner; S H Zinner
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

8.  Cross-resistance of Pseudomonas aeruginosa to ciprofloxacin, extended-spectrum beta-lactams, and aminoglycosides and susceptibility to antibiotic combinations.

Authors:  A W Chow; J Wong; K H Bartlett; S D Shafran; H G Stiver
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

9.  Ofloxacin susceptibility testing quality control parameters for microdilution and disk diffusion, and confirmation of disk diffusion interpretive criteria.

Authors:  P C Fuchs; R N Jones; A L Barry; T L Gavan
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

Review 10.  Impermeability to quinolones in gram-positive and gram-negative bacteria.

Authors:  L E Bryan; J Bedard
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.